Release Date: 30/11/22 12:09 Summary: Hancock Bidder's Statement Price Sensitive: Yes Download Document 3.74MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%